Web20 de mar. de 2024 · Abstract Background Cost and drug toxicity frequently deter the long-term use of anti-tumor necrosis factor (TNF) agents in ankylosing spondylitis (AS). … Web20 de mai. de 2008 · Introduction. Ankylosing spondylitis (AS) has an estimated prevalence of 0.2–0.86% for adult Caucasian populations of western European …
Open Access Full Text Article Long-term safety and efficacy of ...
WebAnkylosing spondylitis (AS) is a type of chronic, inflammatory arthritis that mainly affects the spine. It usually begins in the 20s or 30s with persistent lower back pain and … WebThe present study shows that up to 5% of patients with IBD may have ankylosing spondylitis, and patients withIBD+AS do not have a worse disease outcome than solo … co to jest konflikt
Impact of Secukinumab on Patient-Reported Outcomes in the …
Web9 de fev. de 2024 · Axial Spondyloarthritis, also known as Axial SpA or AS, is an arthritis that mainly affects the spine. Inflammation occurs along the spine where the ligaments or … Web7 de out. de 2024 · Long-term untreated inflammation can cause many complications, including an increased risk for heart disease, gut disorders, and extreme tiredness. … Web8 de fev. de 2024 · The researchers concluded that this information is reassuring for the long-term use of NSAIDs in treating AS. References: Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study. Rheumatology (Oxford) The Heart in Spondylitis … co to jest konsensus